Guru Ownership Trend
Guru Analysis for Beam Therapeutics Inc. (BEAM)
Beam Therapeutics Inc. (BEAM), a key player in the 醫療健康 sector, continues to attract institutional attention.
As of Q3 2025, a total of 3 Super Investors (Gurus) hold positions in the company, with a combined stake valued at approximately $305.47 M.
Top institutional holders include 凱薩琳·伍德 and 克里夫·阿斯內斯.
Institutional sentiment is currently Strongly Bullish. This is evidenced by a $52.27 M net inflow during the quarter.
Recent activity highlights 穆雷·斯塔爾 who opened a new position. Conversely, 克里夫·阿斯內斯 reduced exposure by 55.8%.
| Portfolio Manager | % Portfolio | Activity | Shares | Value | Report Date |
|---|---|---|---|---|---|
| 1.59% | Add 24.8% | 11,038,834 | $267.91 M | Q3 2025 | |
| 0.00% | Reduce -55.8% | 11,226 | $272,455 | Q3 2025 | |
| 0.00% | New Buy | 9,597 | $232,919 | Q3 2025 |
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Report Date | Portfolio Manager | Activity | Share Change | % Portfolio Change |
|---|
| Portfolio Manager | Option Type | % Portfolio | Activity | Shares | Value | Report Date |
|---|
Key Holders
Recent Activity Breakdown (Q3 2025)
Guru Consensus (Q3 2025)
FAQs for Beam Therapeutics Inc. (BEAM)
According to the latest 13F reporting period, sentiment appears Bullish (Net Buying). There was a net inflow of $52.27 M, with 2 managers increasing positions and 2 managers reducing holdings.
During the most recent reporting period, 1 managers trimmed their positions, while 1 fully exited BEAM. The total reported sell value was $1.13 M.
Yes, 1 managers opened new positions in BEAM, and 1 increased their existing holdings. The total reported buy value was $53.41 M.